Machine learning-based exceptional response prediction of nivolumab monotherapy with circulating microRNAs in non-small cell lung cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Machine learning-based exceptional response prediction of nivolumab monotherapy with circulating microRNAs in non-small cell lung cancer
Authors
Keywords
-
Journal
LUNG CANCER
Volume 173, Issue -, Pages 107-115
Publisher
Elsevier BV
Online
2022-09-13
DOI
10.1016/j.lungcan.2022.09.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Identifying the Signatures and Rules of Circulating Extracellular MicroRNA for Distinguishing Cancer Subtypes
- (2021) Fei Yuan et al. Frontiers in Genetics
- MiR-200c-3p Contrasts PD-L1 Induction by Combinatorial Therapies and Slows Proliferation of Epithelial Ovarian Cancer through Downregulation of β-Catenin and c-Myc
- (2021) Eleni Anastasiadou et al. Cells
- Identification of MicroRNA–mRNA Networks in Melanoma and Their Association with PD-1 Checkpoint Blockade Outcomes
- (2021) Robert A. Szczepaniak Sloane et al. Cancers
- Therapy for Stage IV Non–Small-Cell Lung Cancer Without Driver Alterations: ASCO and OH (CCO) Joint Guideline Update
- (2020) Nasser H. Hanna et al. JOURNAL OF CLINICAL ONCOLOGY
- RNA delivery by extracellular vesicles in mammalian cells and its applications
- (2020) Killian O’Brien et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Machine learning identifies 10 feature miRNAs for lung squamous cell carcinoma
- (2020) Zheng Ye et al. GENE
- PD-L1 Under Regulation of miR-429 Influences the Sensitivity of Gastric Cancer Cells to TRAIL by Binding of EGFR
- (2020) Jinqi Lv et al. Frontiers in Oncology
- Association of Short-Chain Fatty Acids in the Gut Microbiome With Clinical Response to Treatment With Nivolumab or Pembrolizumab in Patients With Solid Cancer Tumors
- (2020) Motoo Nomura et al. JAMA Network Open
- Circulating microRNAs and PD-L1 tumor expression are associated with survival in advanced NSCLC patients treated with immunotherapy: a prospective study
- (2019) Mattia Boeri et al. CLINICAL CANCER RESEARCH
- Comparative efficacy and safety of first-line treatments for advanced non-small cell lung cancer with immune checkpoint inhibitors: A systematic review and meta-analysis
- (2019) Rui Chen et al. Thoracic Cancer
- Five-Year Overall Survival for Patients With Advanced Non‒Small-Cell Lung Cancer Treated With Pembrolizumab: Results From the Phase I KEYNOTE-001 Study
- (2019) Edward B. Garon et al. JOURNAL OF CLINICAL ONCOLOGY
- Role of cell surface proteoglycans in cancer immunotherapy
- (2019) Nancy A. Espinoza-Sánchez et al. SEMINARS IN CANCER BIOLOGY
- Circulating microRNAs predict the response to anti-PD-1 therapy in non-small cell lung cancer
- (2019) Jinshuo Fan et al. GENOMICS
- The biochemical basis of microRNA targeting efficacy
- (2019) Sean E. McGeary et al. SCIENCE
- Circulating microRNAs associated with prolonged overall survival in lung cancer patients treated with nivolumab
- (2018) Ann Rita Halvorsen et al. ACTA ONCOLOGICA
- The Role of the Estrogen Pathway in the Tumor Microenvironment
- (2018) Natalie Rothenberger et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- MiR-21 Participates in the PD-1/PD-L1 Pathway-Mediated Imbalance of Th17/Treg Cells in Patients After Gastric Cancer Resection
- (2018) Xiaoyu Zheng et al. ANNALS OF SURGICAL ONCOLOGY
- UMI-tools: modeling sequencing errors in Unique Molecular Identifiers to improve quantification accuracy
- (2017) Tom Smith et al. GENOME RESEARCH
- Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
- (2017) Achim Rittmeyer et al. LANCET
- DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions
- (2017) Dimitra Karagkouni et al. NUCLEIC ACIDS RESEARCH
- New Dancing Couple: PD-L1 and MicroRNA
- (2017) A. Grenda et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Extracellular vesicle transfer of cancer pathogenic components
- (2016) Yu Fujita et al. CANCER SCIENCE
- Expression of programmed death ligand-1 on tumor cells varies pre and post chemotherapy in non-small cell lung cancer
- (2016) Jin Sheng et al. Scientific Reports
- Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
- (2015) Julie Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- featureCounts: an efficient general purpose program for assigning sequence reads to genomic features
- (2013) Y. Liao et al. BIOINFORMATICS
- DIANA-microT web server v5.0: service integration into miRNA functional analysis workflows
- (2013) Maria D. Paraskevopoulou et al. NUCLEIC ACIDS RESEARCH
- Functional microRNA targets in protein coding sequences
- (2012) Martin Reczko et al. BIOINFORMATICS
- Modernizing Reference Genome Assemblies
- (2011) Deanna M. Church et al. PLOS BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started